These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25380207)

  • 1. [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
    Różańska D; Regulska-Ilow B; Choroszy-Król I; Ilow R
    Postepy Hig Med Dosw (Online); 2014 Nov; 68():1251-6. PubMed ID: 25380207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
    Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
    World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic
    Zhao Z; Xu S; Zhang W; Wu D; Yang G
    Food Funct; 2022 Jun; 13(11):5914-5924. PubMed ID: 35583304
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis.
    Losurdo G; Iannone A; Contaldo A; Ierardi E; Di Leo A; Principi M
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):499-505. PubMed ID: 26697577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D; Schulte-Witte H
    Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
    Henker J; Müller S; Laass MW; Schreiner A; Schulze J
    Z Gastroenterol; 2008 Sep; 46(9):874-5. PubMed ID: 18810672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).
    Matthes H; Krummenerl T; Giensch M; Wolff C; Schulze J
    BMC Complement Altern Med; 2010 Apr; 10():13. PubMed ID: 20398311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.
    Burke DA; Axon AT
    BMJ; 1988 Jul; 297(6641):102-4. PubMed ID: 3044496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
    Kruis W; Fric P; Pokrotnieks J; Lukás M; Fixa B; Kascák M; Kamm MA; Weismueller J; Beglinger C; Stolte M; Wolff C; Schulze J
    Gut; 2004 Nov; 53(11):1617-23. PubMed ID: 15479682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.
    Schultz M; Strauch UG; Linde HJ; Watzl S; Obermeier F; Göttl C; Dunger N; Grunwald N; Schölmerich J; Rath HC
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):372-8. PubMed ID: 15013990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.
    Souza ÉL; Elian SD; Paula LM; Garcia CC; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
    J Med Microbiol; 2016 Mar; 65(3):201-210. PubMed ID: 26758971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial.
    Tromm A; Niewerth U; Khoury M; Baestlein E; Wilhelms G; Schulze J; Stolte M
    Z Gastroenterol; 2004 May; 42(5):365-9. PubMed ID: 15136935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
    Xia P; Zhu J; Zhu G
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):538-44. PubMed ID: 24028055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.
    Kruis W; Chrubasik S; Boehm S; Stange C; Schulze J
    Int J Colorectal Dis; 2012 Apr; 27(4):467-74. PubMed ID: 22130826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of
    Oh GM; Moon W; Seo KI; Jung K; Kim JH; Kim SE; Park MI; Park SJ
    Korean J Gastroenterol; 2021 Jan; 77(1):12-21. PubMed ID: 33361702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.
    Joeres-Nguyen-Xuan TH; Boehm SK; Joeres L; Schulze J; Kruis W
    Inflamm Bowel Dis; 2010 Feb; 16(2):256-62. PubMed ID: 19637333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.